Skip to main content

Table 3 Comparison of the body mass index and waist:hip ratio between the two studied groups

From: Amelioration of polycystic ovary syndrome-related disorders by supplementation of thymoquinone and metformin

  

At the beginning of the study

After 3 months

After 6 months

P1

P2

P3

BMI (kg/m2)

Group A

29.65 ± 4.39

28.75 ± 3.98

28.93 ± 3.21

0.14

0.18

0.71

Group B

29.71 ± 4.13

27.88 ± 4.01

24.32 ± 2.28

0.002*

0.00**

0.001**

P

0.93

0.12

0.00**

   

Waist:hip ratio

Group A

0.86 ± 0.05

0.85 ± 0.04

0.84 ± 0.04

0.58

0.36

0.51

Group B

0.85 ± 0.04

0.82 ± 0.08

0.75 ± 0.04

0.24

0.0001**

0.007*

P

0.96

0.86

0.00**

   
  1. *Statistically significant
  2. **Highly significant (≤ 0.001)
  3. P1, beginning of the study compared to after 3 months; P2, beginning of the study compared to after 6 months; P3, after 3 months compared to after 6 months